32 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Molecular Partners Competitors or Alternatives

Molecular Partners's top competitors include Adaptimmune, Harpoon and Ambrx.

Unlock 14 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Molecular Partners's company profile

Patrick Amstutz

Co-Founder & CEO

59/100
163
$347.1M
$10.7M
  • $347.1M
    $10.7M
  • 163
    $347.1M
  • $10.7M
  • 59/100
  • 163
  • $347.1M
  • $10.7M
View ProfileView
1
Molecular Partners's Competitor - Adaptimmune logo

Adrian Rawcliffe

CEO

84/100
506
$683.7M
$178M
  • $683.7M
    $178M
  • 506
    $683.7M
  • $178M
  • 84/100
  • 506
  • $683.7M
  • $178M
View ProfileView
2
Molecular Partners's Competitor - Harpoon logo

CEO

- -
100
$348.3M
$37.3M
  • $348.3M
    $37.3M
  • 100
    $348.3M
  • $37.3M
  • - -
  • 100
  • $348.3M
  • $37.3M
View ProfileView
3
Molecular Partners's Competitor - Ambrx logo

Daniel J. OConnor

CEO

82/100
25 - 100
$717.2M
$100K - 5M
  • $717.2M
    $100K - 5M
  • 25 - 100
    $717.2M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $717.2M
  • $100K - 5M
View ProfileView
4
Molecular Partners's Competitor - Immatics logo

Harpreet Singh

Managing Director & CEO

95/100
343
$610.3M
$81.7M
  • $610.3M
    $81.7M
  • 343
    $610.3M
  • $81.7M
  • 95/100
  • 343
  • $610.3M
  • $81.7M
View ProfileView
5
Molecular Partners's Competitor - Immunocore logo

Bahija Jallal

CEO

64/100
493
$1.5B
$310.2M
  • $1.5B
    $310.2M
  • 493
    $1.5B
  • $310.2M
  • 64/100
  • 493
  • $1.5B
  • $310.2M
View ProfileView
Molecular Partners' top 17 competitors are Adaptimmune, Harpoon, Ambrx, AC Immune, Immatics, Immunocore, Polyphor, TCR2, Basilea, Santhera, BioAtla, Proteostasis Therapeutics, Zymeworks, Sutro Biopharma, Proteon, Gyre Therapeutics and Astex Pharmaceuticals. Together they have raised over 7.5B between their estimated 3.5K employees. Molecular Partners has 163 employees and is ranked 8th among it's top 10 competitors. The top 10 competitors average 203.

Molecular Partners VS Adaptimmune

Adaptimmune is seen as one of Molecular Partners's top competitors. Adaptimmune was founded in Oxfordshire, England} in 2008. Adaptimmune is in the Biotechnology industry. Compared to Molecular Partners, Adaptimmune generates $167.4M more revenue.

Molecular Partners VS Harpoon

Harpoon is Molecular Partners's #2 competitor. Harpoon was founded in 2015, and its headquarters is in South San Francisco, California. Harpoon competes in the Biotechnology industry. Harpoon has 63 fewer employees than Molecular Partners.

Molecular Partners VS Ambrx

Ambrx is Molecular Partners's #3 rival. Ambrx is headquartered in San Diego, California, and was founded in 2003. Like Molecular Partners, Ambrx also competes in the Biotechnology industry. Ambrx generates 38% the revenue of Molecular Partners.

Looking for similar companies to Molecular Partners?

Similar Companies

Companies in Schlieren with revenue in $5.0-25M range

See 16 companies 
Biotechnology companies in Schlieren

See 25 companies 
Biotechnology companies in Zurich

See 72 companies 
Pharmaceuticals & Biotechnology companies in Schlieren

See 32 companies 
Pharmaceuticals & Biotechnology companies in Zurich

See 116 companies 
Companies in Zurich with employees in 100-250 range

See 219 companies 
Biotechnology companies in Switzerland

See 406 companies 
Companies in Zurich with revenue in $5.0-25M range

See 455 companies 
Pharmaceuticals & Biotechnology companies in Switzerland

See 793 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Molecular Partners and Molecular Partners's Competitors

April 29, 2025Marketscreener
SAN DIEGO , April 29, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development o...
April 28, 2025Benzinga
SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneer...
April 29, 2025FinanzNachrichten
Transformational year following the successful launch of AGAMREE® Pratteln, Switzerland, April 29, 2025 - Santhera Pharmaceuticals (SIX: SANN) today an...
Today 11:32 AMGlobeNewswire
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update...
April 28, 2025Seeking Alpha
April 29, 2025Benzinga
Novartis AG NVS reported first-quarter 2025 adjusted earnings per share of $2.28, beating the street view of $2.10 . Quarterly sales of $13.23 billion ...
April 29, 2025centralcharts
An exposure-outcome analysis in 72 patients with refractory non-small cell lung cancer (NSCLC) who received AFM24 at 480 mg weekly demonstrates that hi...
April 29, 2025Marketscreener
Pfizer Inc. reported earnings results for the first quarter ended March 30, 2025. For the first quarter, the company reported revenue was USD 13,715 mi...
April 28, 2025Seeking Alpha
April 29, 2025The Wall Street Journal
Novartis raised its 2025 outlook after its core operating profit rose 23% on year, boosted by strong demand for its key drugs....

Frequently Asked Questions about Molecular Partners

  1. Who are Molecular Partners's top competitors?

    Molecular Partners's top 3 competitors are Adaptimmune, Harpoon, Ambrx.

  2. Who is similar to Molecular Partners?

    Adaptimmune is the most similar to Molecular Partners. Harpoon and Ambrx are also similar to Molecular Partners.

  1. Are Molecular Partners and Adaptimmune competitors?

    Yes, Adaptimmune is one of Molecular Partners’s top competitors.